Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESRA: Palovarotene in Emphysema-predominant COPD
NCT00413205Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Primary completion
- May 2010
- Countries
- 12
01
Overview
A Phase 2 trial of palovarotene in chronic obstructive pulmonary disease (COPD), emphysema, sponsored by Roche. Started Jan 2007; status: completed.
02
Drugs
palovarotene
03
Conditions
chronic obstructive pulmonary disease (COPD)emphysema
Beyond the preview
Go deeper on NCT00413205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413205.